Get a full Dropbox share (approx. US$23) for each referral this June.
Start referring
Stake logo

by Stella Ong
Share

Immortal

We recently discussed how 3D printing can already produce organs (albeit not fit for human transplants yet). Interestingly, this is just one component of a whole domain of tech dedicated to extending human life: “immortality-as-a-service” or “IaaS”.

Estimated to reach a market value of US$64b by 2026, IaaS is yet to be accurately defined, currently falling between the healthcare and cloud industries. The term is also used in reference to both biological and digital immortality.

Biological immortality is pretty straightforward: scientists working on extending life through medical advancements, including 3D printing (as mentioned), gene therapy and nanotechnology. The field has generated a lot of investor interest in the recent years, leading to stand-alone companies like Unity Biotechnology ($UBX) and established tech companies like Google ($GOOGL) having enough funding to focus exclusively on the research. Studies have already gone far, with a certain biotech CEO setting an example. Bryan Johnson is 45 years old, but test results show that, biologically, he has a heart of a 37-year-old, skin of a 28-year-old and lungs of an 18-year-old. While impressive, his upkeep reportedly costs US$2m a year

Digital immortality is, comparatively, the cheap option. Instead of dropping two mill a year on advanced self-care, you may soon be able to “upload your personality” into a computer. This would allow you to transcend mortality in a way, and continue to digitally keep your loved ones company. Despite this raising plenty of questions on existentialism, the concept is popular among Metaverse companies and research is forging ahead.

Would you rather see advancements in biological or digital immortality – or do you think eternal life is overrated anyway?


Portrait photo of Stella Ong, Markets Analyst at Stake.

Stella Ong

Markets Analyst

Stella is a markets analyst and writer with almost a decade of investing experience. With a Masters in Accounting from the University of Sydney, she specialises in financial statement analysis and financial modelling. Previously, she worked as an equity analyst at Australian finance start-up, Simply Wall St, where she took charge of the market insights newsletter sent out to over a million subscribers. At Stake, Stella has been key to producing the weekly Wrap articles and social media content.


Don’t have Stake?

Get $10 when you fund Stake AUS, a free US stock when you fund Stake Wall St. Do both, get both! Terms & Conditions.


Related


Stake logo
App Store logoGoogle Play logo

Subscribe to our free newsletters


Stakeshop Pty Ltd, trading as Stake, ACN 610105505, is an authorised representative (Authorised Representative No. 1241398) of Sanlam Private Wealth Pty Ltd (Australian Financial Services Licence No. 337927) ('Sanlam') and an authorised representative (Authorised Representative No. 1241398) of Airwallex Pty Ltd (Australian Financial Services Licence No. 487221) ('Airwallex'). Stake is not authorised by Airwallex under Airwallex’s AFSL to arrange for clients to be issued with securities as Airwallex is not authorised under its AFSL for this purpose. Stake is not authorised by Sanlam under Sanlam’s AFSL to arrange for clients to be issued with a non-cash payment facility as Sanlam is not authorised under its AFSL for this purpose. Stake SMSF Pty Ltd (‘Stake Super’) is not licensed to provide financial product advice under the Corporations Act. This specifically applies to any financial products which are established if you instruct Stake Super to set up a self managed super fund (‘SMSF’). When you sign up to Stake Super, you are contracting with Stake SMSF Pty Ltd who will assist in the establishment of a SMSF under a ‘no advice model’. You will also be referred to Stakeshop Pty Ltd to enable your trading account and bank account to be set up in order to use the Stake Website and/or App. Stakeshop Pty Ltd will also run marketing and promotions to you under. For more information about SMSFs, see our SMSF Risks page.The information on our website or our mobile application is not intended to be an inducement, offer or solicitation to anyone in any jurisdiction in which Stake is not regulated or able to market its services. At Stake and Stake Super, we’re focused on giving you a better investing experience but we don’t take into account your personal objectives, circumstances or financial needs. Any advice given by Stake is of a general nature only. As investments carry risk, before making any investment decision, please consider if it’s right for you and seek appropriate taxation and legal advice. Please view our Financial Services GuideTerms & ConditionsPrivacy Policy and Disclaimers  before deciding to invest on or use Stake or Stake Super. By using our website or service in any way, you agree to our Privacy Policy and Terms & Conditions. All financial products involve risk and you should ensure you understand the risks involved as certain financial products may not be suitable to everyone. Past performance of any product described on this website is not a reliable indication of future performance. Stake and Stake Super are registered trademarks in Australia.

Copyright © 2023 Stake. All rights reserved.